» Articles » PMID: 36616166

Three Parts of the Plant Genome: On the Way to Success in the Production of Recombinant Proteins

Overview
Journal Plants (Basel)
Date 2023 Jan 8
PMID 36616166
Authors
Affiliations
Soon will be listed here.
Abstract

Recombinant proteins are the most important product of current industrial biotechnology. They are indispensable in medicine (for diagnostics and treatment), food and chemical industries, and research. Plant cells combine advantages of the eukaryotic protein production system with simplicity and efficacy of the bacterial one. The use of plants for the production of recombinant proteins is an economically important and promising area that has emerged as an alternative to traditional approaches. This review discusses advantages of plant systems for the expression of recombinant proteins using nuclear, plastid, and mitochondrial genomes. Possibilities, problems, and prospects of modifications of the three parts of the genome in light of obtaining producer plants are examined. Examples of successful use of the nuclear expression platform for production of various biopharmaceuticals, veterinary drugs, and technologically important proteins are described, as are examples of a high yield of recombinant proteins upon modification of the chloroplast genome. Potential utility of plant mitochondria as an expression system for the production of recombinant proteins and its advantages over the nucleus and chloroplasts are substantiated. Although these opportunities have not yet been exploited, potential utility of plant mitochondria as an expression system for the production of recombinant proteins and its advantages over the nucleus and chloroplasts are substantiated.

Citing Articles

Morphological Structure Identification, Comparative Mitochondrial Genomics and Population Genetic Analysis toward Exploring Interspecific Variations and Phylogenetic Implications of 'ZA' and Other Species.

Wang X, Wang D, Zhang R, Qin X, Shen X, You C Biomolecules. 2024; 14(8).

PMID: 39199300 PMC: 11352593. DOI: 10.3390/biom14080912.

References
1.
Mardanov A, Ravin N, Kuznetsov B, Samigullin T, Antonov A, Kolganova T . Complete sequence of the duckweed (Lemna minor) chloroplast genome: structural organization and phylogenetic relationships to other angiosperms. J Mol Evol. 2008; 66(6):555-64. DOI: 10.1007/s00239-008-9091-7. View

2.
Pillet S, Couillard J, Trepanier S, Poulin J, Yassine-Diab B, Guy B . Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine candidate-Two randomized Phase II clinical trials in 18 to 49 and ≥50 years old adults. PLoS One. 2019; 14(6):e0216533. PMC: 6550445. DOI: 10.1371/journal.pone.0216533. View

3.
Schillberg S, Raven N, Spiegel H, Rasche S, Buntru M . Critical Analysis of the Commercial Potential of Plants for the Production of Recombinant Proteins. Front Plant Sci. 2019; 10:720. PMC: 6579924. DOI: 10.3389/fpls.2019.00720. View

4.
Ma J, Drossard J, Lewis D, Altmann F, Boyle J, Christou P . Regulatory approval and a first-in-human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants. Plant Biotechnol J. 2015; 13(8):1106-20. DOI: 10.1111/pbi.12416. View

5.
Nakazato I, Okuno M, Zhou C, Itoh T, Tsutsumi N, Takenaka M . Targeted base editing in the mitochondrial genome of . Proc Natl Acad Sci U S A. 2022; 119(20):e2121177119. PMC: 9171795. DOI: 10.1073/pnas.2121177119. View